Status:
COMPLETED
Hip Denervation in Juvenile Idiopathic Arthritis With Hip Arthritis
Lead Sponsor:
Sohag University
Conditions:
Juvenile Idiopathic Arthritis
Hip Arthritis
Eligibility:
All Genders
2-18 years
Phase:
PHASE3
Brief Summary
Patients having juvenile idiopathic arthritis (according to ILAR criteria) with hip arthritis were divided into 3 groups. Group 1 received hip denervation and group 2 controlled and received a subcuta...
Detailed Description
The aim of the study is to test the effect of denervation of the active hip in JIA and compare it with a placebo without changing systemic treatment during the study. Outcome measures included pain, r...
Eligibility Criteria
Inclusion
- patients with JIA with unilateral hip arthritis
Exclusion
- hip involvement due to other causes including
- septic arthritis
- other connective tissue diseases
- Avascular necrosis
Key Trial Info
Start Date :
January 6 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 6 2021
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04775225
Start Date
January 6 2021
End Date
April 6 2021
Last Update
January 17 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ahmed Elsaman
Sohag, Egypt, 82749